Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients

NCT00395460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Diseases

Interventions

DRUG: Gadobutrol (Gadavist, Gadovist, BAY86-4875)
DRUG: Magnevist

Sponsor

Bayer